Alnylam Pharmaceuticals Inc (ALNY)
246.80
-1.99
(-0.80%)
USD |
NASDAQ |
Nov 21, 16:00
247.11
+0.31
(+0.13%)
Pre-Market: 08:16
Alnylam Pharmaceuticals Total Assets (Quarterly): 4.205B for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 4.205B |
| June 30, 2024 | 4.010B |
| March 31, 2024 | 3.824B |
| December 31, 2023 | 3.830B |
| September 30, 2023 | 3.839B |
| June 30, 2023 | 3.402B |
| March 31, 2023 | 3.392B |
| December 31, 2022 | 3.546B |
| September 30, 2022 | 3.535B |
| June 30, 2022 | 3.330B |
| March 31, 2022 | 3.434B |
| December 31, 2021 | 3.643B |
| September 30, 2021 | 3.472B |
| June 30, 2021 | 3.509B |
| March 31, 2021 | 3.255B |
| December 31, 2020 | 3.407B |
| September 30, 2020 | 3.307B |
| June 30, 2020 | 3.374B |
| March 31, 2020 | 2.280B |
| December 31, 2019 | 2.395B |
| September 30, 2019 | 2.542B |
| June 30, 2019 | 2.716B |
| March 31, 2019 | 2.014B |
| December 31, 2018 | 1.575B |
| September 30, 2018 | 1.676B |
| Date | Value |
|---|---|
| June 30, 2018 | 1.789B |
| March 31, 2018 | 1.923B |
| December 31, 2017 | 1.995B |
| September 30, 2017 | 1.358B |
| June 30, 2017 | 1.434B |
| March 31, 2017 | 1.134B |
| December 31, 2016 | 1.263B |
| September 30, 2016 | 1.313B |
| June 30, 2016 | 1.382B |
| March 31, 2016 | 1.317B |
| December 31, 2015 | 1.387B |
| September 30, 2015 | 1.436B |
| June 30, 2015 | 1.531B |
| March 31, 2015 | 1.629B |
| December 31, 2014 | 1.080B |
| September 30, 2014 | 986.36M |
| June 30, 2014 | 1.033B |
| March 31, 2014 | 1.080B |
| December 31, 2013 | 420.53M |
| September 30, 2013 | 447.50M |
| June 30, 2013 | 462.56M |
| March 31, 2013 | 471.58M |
| December 31, 2012 | 287.52M |
| September 30, 2012 | 322.35M |
| June 30, 2012 | 318.48M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
2.280B
Minimum
Mar 2020
4.205B
Maximum
Sep 2024
3.450B
Average
3.453B
Median
Total Assets (Quarterly) Benchmarks
| Pfizer Inc | 219.48B |
| BridgeBio Pharma Inc | 664.98M |
| Gilead Sciences Inc | 54.52B |
| Johnson & Johnson | 178.29B |
| Regeneron Pharmaceuticals Inc | 37.44B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 4.173B |
| Shareholders Equity (Quarterly) | 32.35M |
| Debt to Equity Ratio | 31.64 |
| Current Ratio | 2.749 |
| Net Debt Paydown Yield | -0.00% |